Superworth

Embecta profit margin EMBC

Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.

Net margin, 12 months
8.6%
Operating margin, 12 months
21.9%
Net margin on a year earlier
+1.0 pts
Peer median
6.5%

Over the twelve months to Jun 30, 2026, Embecta kept 8.6% of its revenue as net profit, with an operating margin of 21.9% and a gross margin of 59.0%.

The median for 10 medical instruments and supplies stocks of a similar size is 6.5%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY20258.8%22.4%62.6%
FY20247.0%14.9%65.5%
FY20236.3%19.8%66.9%
FY202219.8%27.4%68.6%
FY202135.6%42.2%68.7%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q3 FY268.6%+1.0 pts21.9%
Q2 FY2610.7%+5.8 pts25.8%
Q1 FY2612.9%+7.7 pts27.5%
Q4 FY258.8%+1.9 pts22.4%
Q3 FY257.6%+1.4 pts19.2%
Q2 FY254.9%−1.3 pts16.1%
Q1 FY255.3%+0.3 pts13.5%
Q4 FY247.0%+0.7 pts14.9%
Q3 FY246.2%+2.0 pts14.9%
Q2 FY246.2%−2.2 pts14.3%
Q1 FY244.9%−9.4 pts15.9%
Q4 FY236.3%−13.5 pts19.8%

Against its peers

Companies in Medical - Instruments & Supplies nearest Embecta's size, closest first, today.

CompanyProfit margin
EMBCEmbecta8.6%
INFUInfuSystem6.0%
TCMDTactile Systems Technology7.1%
MDXGMimedx1.8%
UTMDUtah Medical Products29.0%
MOVMovado6.0%
PDEXPro DEX17.6%
IRMDIradimed26.7%
STAAStaar Surgical1.1%
BVSBioventus9.4%
CDRECadre5.3%
Peer median6.5%

Where Embecta ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Embecta

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.